Search Results - "Silver, Lewis"

Refine Results
  1. 1

    DICOMweb™: Background and Application of the Web Standard for Medical Imaging by Genereaux, Brad W., Dennison, Donald K., Ho, Kinson, Horn, Robert, Silver, Elliot Lewis, O’Donnell, Kevin, Kahn, Charles E.

    Published in Journal of digital imaging (01-06-2018)
    “…This paper describes why and how DICOM, the standard that has been the basis for medical imaging interoperability around the world for several decades, has…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4

    Ocular Comfort of Brinzolamide 1.0% Ophthalmic Suspension Compared With Dorzolamide 2.0% Ophthalmic Solution: Results From Two Multicenter Comfort Studies by Silver, Lewis H, the Brinzolamide Comfort Study Group

    Published in Survey of ophthalmology (2000)
    “…Two independent, prospective, multicenter, double-masked, parallel group trials were conducted to compare the ocular comfort of brinzolamide 1.0% administered…”
    Get full text
    Journal Article
  5. 5

    Comparison of travoprost 0.0015% and 0.004% with timolol 0.5% in patients with elevated intraocular pressure: a 6-month, masked, multicenter trial by Fellman, Ronald L, Sullivan, E Kenneth, Ratliff, Marla, Silver, Lewis H, Whitson, Jess T, Turner, F Darell, Weiner, Alan L, Davis, Alberta A

    Published in Ophthalmology (Rochester, Minn.) (01-05-2002)
    “…To compare the safety and intraocular pressure (IOP)-lowering efficacy of once-daily travoprost (0.0015% and 0.004%) to twice-daily timolol 0.5%. Prospective,…”
    Get more information
    Journal Article
  6. 6

    Clinical efficacy and safety of brinzolamide (Azopt™), a new topical carbonic anhydrase inhibitor for primary open-angle glaucoma and ocular hypertension by Silver, Lewis H.

    Published in American journal of ophthalmology (01-09-1998)
    “…PURPOSE: To determine the intraocular pressure-lowering efficacy and safety of brinzolamide 1.0%, compared with dorzolamide 2.0% and timolol 0.5%. METHODS: A…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Clinical Safety of Moxifloxacin Ophthalmic Solution 0.5% (VIGAMOX®) in Pediatric and Nonpediatric Patients With Bacterial Conjunctivitis by Silver, Lewis H., Woodside, Adrienne M., Montgomery, Dawnelle B.

    Published in Survey of ophthalmology (01-11-2005)
    “…Five independent, multicentered, double-masked, parallel, controlled studies were conducted to determine the safety of moxifloxacin ophthalmic solution 0.5%…”
    Get full text
    Journal Article
  9. 9

    Evaluation of travoprost as adjunctive therapy in patients with uncontrolled intraocular pressure while using timolol 0.5 by Orengo-Nania, Silvia, Landry, Theresa, Von Tress, Mark, Silver, Lewis H, Weiner, Alan, Davis, Alberta A

    Published in American journal of ophthalmology (01-12-2001)
    “…PURPOSE: To evaluate the intraocular pressure-lowering efficacy and safety of travoprost 0.0015% and 0.004%, dosed daily in the evening compared with vehicle,…”
    Get full text
    Journal Article
  10. 10
  11. 11
  12. 12

    Long-term intraocular pressure–lowering efficacy and safety of timolol maleate gel-forming solution 0.5% compared with timoptic XE 0.5% in a 12-month study by Schenker, Howard I, Silver, Lewis H

    Published in American journal of ophthalmology (01-08-2000)
    “…PURPOSE: To evaluate the long-term intraocular pressure–lowering efficacy and safety of timolol maleate gel-forming solution 0.5% (Timolol GFS 0.5%, Alcon…”
    Get full text
    Journal Article
  13. 13

    Travoprost compared with latanoprost and timolol in patients with open-angle glaucoma or ocular hypertension by Netland, Peter A, Landry, Theresa, Sullivan, E.Kenneth, Andrew, Russell, Silver, Lewis, Weiner, Alan, Mallick, Sushanta, Dickerson, Jaime, Bergamini, M.V.W, Robertson, S.M, Davis, Alberta A

    Published in American journal of ophthalmology (01-10-2001)
    “…PURPOSE: This study evaluated the safety and intraocular pressure–lowering efficacy of two concentrations of travoprost (0.0015% and 0.004%) compared with…”
    Get full text
    Journal Article
  14. 14

    Dose-Response Evaluation of the Ocular Hypotensive Effect of Brinzolamide Ophthalmic Suspension (Azopt ®) by Silver, Lewis H., the Brinzolamide Dose-Response Study Group

    Published in Survey of ophthalmology (2000)
    “…Brinzolamide is a novel carbonic anhydrase inhibitor that elicits an ocular hypotensive effect when instilled topically. A multicenter, double-masked,…”
    Get full text
    Journal Article
  15. 15
  16. 16
  17. 17

    Response to travoprost in black and nonblack patients with open-angle glaucoma or ocular hypertension by NETLAND, Peter A, ROBERTSON, Stella M, KENNETH SULLIVAN, E, SILVER, Lewis, BERGAMINI, Michael V. W, KRUEGER, Scott, WEINER, Alan L, DAVIS, Alberta A

    Published in Advances in therapy (01-05-2003)
    “…Two prospective, controlled, multicenter, double-masked studies--one lasting 6 months (n=594) and the other, 12 months (n=787)--examined the intraocular…”
    Get full text
    Journal Article
  18. 18
  19. 19
  20. 20